Faruqi and Faruqui, LLP Logo
Share this page

Pharmaceutical Litigation

Faruqi & Faruqi LLP is well equipped to represent patients and their families who are victims of injury and death from drugs and medical devices that are dangerous or carry insufficient warnings about side effects, including death. We have a dedicated team of lawyers who are experienced in bringing high-value cases against well-funded drug and medical device companies, and who get results that focus on the needs of patients and their families who have suffered significant and permanent neurological, cardiovascular, orthopedic, and hematological effects, including death.

Several drug and medical device cases are ongoing in state and federal courts throughout the country. A partial listing, including the total number of cases filed by firms across the nation, includes:

•   In re Ethicon, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2327 (S.D. W. Va.) (40,000 cases filed)

•   In re Xarelto (Rivaroxaban) Products Liability Litigation, MDL No. 2592 (E.D. La.) (18,000 cases filed)

•   In re Boston Scientific Corp. Pelvic Repair System Products Liability Litigation, MDL No. 2326 (S.D. W. Va.) (25,000 cases filed)

•   In re DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation, MDL No. 2244 (N.D. Tex.) (9,000 cases filed)

•   In re Testosterone Replacement Therapy Products Liability Litigation, MDL No. 2545 (N.D. Ill.) (7,000 cases filed)

•   In re C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2187 (S.D. W. Va.) (15,000 cases filed)

•   In re Fresenius GranuFlo/NaturaLyte Dialysate Products Liability Litigation, MDL No. 2428 (D. Mass.) (4,300 cases filed)

•   In re American Medical Systems, Inc., Pelvic Repair System Products Liability Litigation, MDL No. 2325 (S.D. W. Va.) (21,000 cases filed)

•   In re Cook Medical, Inc., Intravenous Catheter Filters Marketing, Sales Practices and Products Liability Litigation, MDL No. 2570 (S.D. Ind.) (2,400 cases filed)

•   In re Bard Intravenous Catheter Filters Products Liability Litigation, MDL No. 2641 (D. Ariz.) (2,400 cases filed)

•   In re Benicar (Olmesartan) Products Liability Litigation, MDL No. 2606 (D.N.J.) (2,200 cases filed)

•   In re Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441 (D. Minn.) (3,400 cases filed)

•   In re DePuy Orthopaedics, Inc., ASR Hip Implant Products Liability Litigation, MDL No. 2197 (N.D. Ohio) (10,000 cases filed)

•   In re Taxotere (Docetaxel) Products Liability Litigation, MDL No. 2740 (E.D. La.) (1,500 cases filed)

•   In re Propecia (Finasteride) Products Liability Litigation, MDL No. 2331 (E.D.N.Y.) (1,100 cases filed)

•   In re Fluoroquinolone Products Liability Litigation, MDL No. 2642 (D. Minn.) (1,000 cases filed)

•   In re Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation, MDL No. 2738 (D.N.J.) (700 cases filed)

•   In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2100 (S.D. Ill.) (11,500 cases filed)

•   In re Invokana (Canagliflozin) Products Liability Litigation, MDL No. 2750 (D.N.J.) (670 cases filed)

•   In re Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, MDL No. 2329 (N.D. Ga.) (600 cases filed)

•   In re Viagra (Sildenafil Citrate) and Cialis (Tadalafil) Products Liability Litigation, MDL No. 2691 (N.D. Cal.) (500 cases filed)

•   In re Zofran (Ondansetron) Products Liability Litigation, MDL No. 2657 (D. Mass) (500 cases filed)

•   In re Plavix Marketing, Sales Practices and Products Liability Litigation (No. II), MDL No. 2418 (D.N.J.) (300 cases filed)

•   In re Abilify (Aripiprazole) Products Liability Litigation, MDL No. 2734 (N.D. Fla.) (225 cases filed)